The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases

European Journal of Surgical Oncology

Volumn 39, Issue 3, 2013, Pages 304-310

  Zdzienicki, M ^a   Rutkowski, P ^a   Nowecki, Z I ^a   Van Akkooi, A C J ^b   Michej, W ^a   Dziewirski, W ^a   Switaj T ^a   Pienkowski A ^a   Salamacha M ^a   Bylina, E ^a   Eggermont, A M M ^c  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Iliac; Inguinal; Lymph node dissection; Melanoma; Sentinel node biopsy; Tumour burden

Indexed keywords

ARTICLE; CANCER PATIENT; CYTOPATHOLOGY; FEMALE; HUMAN; HUMAN TISSUE; ILIAC OBTURATOR NODE; INGUINAL METASTASIS; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; FEMALE; HUMANS; INGUINAL CANAL; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; POLAND; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84874105555     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.12.014     Document Type: Article

References (36)

1. S.E. Singletary, R. Shallenberger, and V.F. Guinee Surgical management of groin nodal metastases from primary melanoma of the lower extremity Surg Gynecol Obstet 174 3 1992 195 200
2. T.M. Hughes, and J.M. Thomas Combined inguinal and pelvic lymph node dissection for stage III melanoma Br J Surg 86 12 1999 1493 1498
3. P. Shen, A.M. Conforti, R. Essner, A.J. Cochran, R.R. Turner, and D.L. Morton Is the node of Cloquet the sentinel node for the iliac/obturator node group? Cancer J 6 2 2000 93 97
4. R. Essner, R. Scheri, M. Kavanagh, H. Torisu-Itakura, L.A. Wanek, and D.L. Morton Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection Arch Surg 141 9 2006 877 882 discussion 882-4
5. C.M. Balch, J.E. Gershenwald, and S.J. Soong Multivariate analysis of prognostic factors among 2313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases J Clin Oncol 28 14 2010 2452 2459
6. A.C. van Akkooi, J.H. de Wilt, and C. Verhoef Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol 17 10 2006 1578 1585
7. A.C. van Akkooi, Z.I. Nowecki, and C. Voit Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes Ann Surg 248 6 2008 949 955
8. C.M. Balch, J.E. Gershenwald, and S.J. Soong Final version of 2009 AJCC melanoma staging and classification J Clin Oncol 27 36 2009 6199 6206
9. Z.I. Nowecki, P. Rutkowski, A. Nasierowska-Guttmejer, and W. Ruka Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes-one institution's experience Melanoma Res 13 1 2003 35 43
10. D.J. Dewar, B. Newell, M.A. Green, A.P. Topping, B.W. Powell, and M.G. Cook The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement J Clin Oncol 22 16 2004 3345 3349
11. C.P. Karakousis Therapeutic node dissections in malignant melanoma Ann Surg Oncol 5 6 1998 473 482
12. A.J. Spillane, L. Haydu, W. McMillan, J.R. Stretch, and J.F. Thompson Quality assurance parameters and predictors of outcome for ilioinguinal and inguinal dissection in a contemporary melanoma patient population Ann Surg Oncol 18 9 2011 2521 2528
13. C.M. Balch, S.-J. Soong, and R. Desmond In reply J Clin Oncol 23 36 2005 9428
14. D. Berd, M.J. Mastrangelo, and T. Sato Calculation of survival of patients with stage III melanoma J Clin Oncol 23 36 2005 9427 author reply 9428
15. Z.I. Nowecki, P. Rutkowski, and W. Michej The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3) Ann Surg Oncol 15 8 2008 2223 2234
16. C.P. Karakousis, and D.L. Driscoll Groin dissection in malignant melanoma Br J Surg 81 12 1994 1771 1774
17. C.M. Balch, and M.I. Ross Melanoma patients with iliac nodal metastases can be cured Ann Surg Oncol 6 3 1999 230 231
18. G.B. Mann, and D.G. Coit Does the extent of operation influence the prognosis in patients with melanoma metastatic to inguinal nodes? Ann Surg Oncol 6 3 1999 263 271
19. A.P. van der Ploeg, A.C. van Akkooi, and P.I. Schmitz Therapeutic surgical management of palpable melanoma groin metastases: superficial or combined superficial and deep groin lymph node dissection Ann Surg Oncol 2011
20. A.L. Shada, and C.L. Slingluff Jr. Regional control and morbidity after superficial groin dissection in melanoma Ann Surg Oncol 18 5 2011 1453 1459
21. B. Badgwell, Y. Xing, and J.E. Gershenwald Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma Ann Surg Oncol 14 10 2007 2867 2875
22. M. Santinami, A. Carbone, and F. Crippa Radical dissection after positive groin sentinel biopsy in melanoma patients: rate of further positive nodes Melanoma Res 19 2 2009 112 118
23. S. Retsas, and M.J. Mastrangelo Reflecting on the 2001 American Joint Committee on cancer staging system for melanoma Semin Oncol 34 6 2007 491 497
24. A.C. van Akkooi, M.G. Bouwhuis, J.H. de Wilt, M. Kliffen, P.I. Schmitz, and A.M. Eggermont Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma Br J Surg 94 10 2007 1293 1299
25. S. Pasquali, S. Mocellin, and L.G. Campana Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases: personal experience and literature meta-analysis Cancer 116 5 2010 1201 1209
26. I.M. van der Ploeg, R.A. Valdes Olmos, B.B. Kroon, and O.E. Nieweg Tumor-positive sentinel node biopsy of the groin in clinically node-negative melanoma patients: superficial or superficial and deep lymph node dissection? Ann Surg Oncol 15 5 2008 1485 1491
27. I.M. van der Ploeg, R.A. Valdes Olmos, and B.B. Kroon The yield of SPECT/CT for anatomical lymphatic mapping in patients with melanoma Ann Surg Oncol 16 6 2009 1537 1542
28. A.C. van Akkooi, J.H. de Wilt, C. Verhoef, and A.M. Eggermont The Rotterdam criteria for sentinel node tumor load: the simplest prognostic factor? J Clin Oncol 26 36 2008 6011 author reply 6012
29. C.K. Chu, K.A. Delman, G.W. Carlson, A.C. Hestley, and D.R. Murray Inguinopelvic lymphadenectomy following positive inguinal sentinel lymph node biopsy in melanoma: true frequency of synchronous pelvic metastases Ann Surg Oncol 2011
30. L.J. Strobbe, A. Jonk, A.A. Hart, O.E. Nieweg, and B.B. Kroon Positive iliac and obturator nodes in melanoma: survival and prognostic factors Ann Surg Oncol 6 3 1999 255 262
31. T.M. Hughes, R.P. A'Hern, and J.M. Thomas Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma Br J Surg 87 7 2000 892 901
32. T.P. Kingham, K.S. Panageas, C.E. Ariyan, K.J. Busam, M.S. Brady, and D.G. Coit Outcome of patients with a positive sentinel lymph node who do not undergo completion lymphadenectomy Ann Surg Oncol 17 2 2010 514 520
33. M.S. Sabel, K.A. Griffith, and A. Arora Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy Surgery 141 6 2007 728 735
34. A.A. Sarnaik, C.A. Puleo, J.S. Zager, and V.K. Sondak Limiting the morbidity of inguinal lymphadenectomy for metastatic melanoma Cancer Control 16 3 2009 240 247
35. M.B. Faries, J.F. Thompson, and A. Cochran The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I) Ann Surg Oncol 17 12 2010 3324 3329
36. A.C. van Akkooi, C.A. Voit, C. Verhoef, and A.M. Eggermont New developments in sentinel node staging in melanoma: controversies and alternatives Curr Opin Oncol 22 3 2010 169 177